Johnson & Johnson
Pharmaceuticals
Company Summary
Johnson & Johnson, a global healthcare leader, has made a lot of sustainable progress by incorporating ESG principles into its operations. The company is committed to sustainable practices, including carbon neutrality and waste reduction, aiming for net-zero emissions by 2030. J&J's ESG rating reflects its positive efforts in improving healthcare access and investing in philanthropy. However, the company has faced ongoing legal and governance issues, particularly related to lawsuits concerning its talcum powder products, which have raised concerns about corporate ethics and accountability. Despite these challenges, Johnson & Johnson’s ESG score is bolstered by its contributions to global health, including COVID-19 vaccine development and its focus on diversity and inclusion. For more insights into Johnson & Johnson's ESG practices, refer to the latest Johnson & Johnson ESG report, which details the company’s progress and areas for improvement. The company has a medium ESG risk, medium exposure to material ESG issues, and a strong score in managing those issues, particularly in areas like corporate governance, human capital, business ethics, and product governance. Despite this, Johnson & Johnson has faced some controversies regarding product quality and safety. They have not yet set a decarbonisation target or specific climate goals, but their ESG strategy is aligned with long-term objectives aimed at reducing their carbon footprint. To learn more about their commitment to health and environmental sustainability, you can download the Johnson and Johnson CSR report and Health for Humanity report above. Johnson & Johnson’s sustainability initiatives focus on creating healthy communities and empowering employees to take action for a healthier world. The company is committed to a healthy planet by increasing its reliance on renewable energy sources, reducing electricity needs, and protecting natural resources. Their ESG strategy is framed by the Global Reporting Initiative (GRI) and other reporting frameworks to ensure transparency. Johnson & Johnson aims to transform healthcare and social well-being by addressing environmental and social issues. Their commitment to a healthier future is linked to their efforts in environmental protection, climate action, and improving the health of the communities they serve.
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
LSEG
Overall ESG Rating :
MSCI
Overall ESG Rating :
J&J is Average among 236 companies in the pharmaceuticals industry.
Temperature Rise :
News from Johnson & Johnson
Taking on the Most Urgent Healthcare Needs in the World
Johnson & Johnson names Honeywell's CEO to its board
Johnson & Johnson is a 2022 Fortune World's Most Admired Company and pharmaceutical industry leader
Providing an Award-Winning Diversity and Inclusion Model
By 2023, all of Johnson & Johnson's facilities in the United States, Canada, and Europe will use only renewable energy, marking a significant step toward the company's climate ambitions
FAQ
What is Johnson & Johnson's ESG score?
Johnson & Johnson has an ESG score of 68/100 (according to Sustainalytics), reflecting its dedication to environmental responsibility, social impact, and strong governance practices.
How does Johnson & Johnson handle ESG issues?
Johnson & Johnson addresses ESG issues by prioritizing sustainable business practices, reducing environmental impact, and improving healthcare access globally. The company focuses on transparency and accountability in all aspects of its operations.
What sustainability practices does Johnson & Johnson follow?
Johnson & Johnson follows sustainability practices like reducing carbon emissions, promoting renewable energy, minimizing waste, and ensuring sustainable sourcing of materials. They also invest in innovative healthcare solutions to improve global health.